首页 >
法规速递
-
Page: Class III implantable devices and Class IIb medical devices intended to administer or remove medicinal products: expert panel opinions-2026/4/29
2026-04-30查看详情 > -
Information Requests and Discipline Review Letters Under the Generic Drug User Fee Amendments (Final)-2022/10/5
2022-11-15查看详情 > -
Draft Guidance: Over-the-Counter Monograph Order Requests: Format and Content-2023/4/12
2023-04-13查看详情 > -
药品经营和使用质量监督管理办法-2023/10/13
2023-10-13查看详情 > -
Document: Opinion of the CVMP on the establishment of maximum residue limits: Rafoxanide-2025/1/7
2025-01-08查看详情 > -
国家药监局关于注销肺结节CT图像辅助检测软件等3个医疗器械注册证书的公告（2025年第5号）-2025/2/17
2025-02-18查看详情 > -
Document: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure-2025/3/25
2025-03-26查看详情 > -
Document: EudraVigilance Expert Working Group (EV-EWG) work programme 2025-2026-2025/4/28
2025-04-29查看详情 > -
Document: Minutes of the CHMP meeting 27-30 January 2025-2025/6/5
2025-06-06查看详情 > -
药你知道 | 《国家药监局关于发布优化全生命周期监管支持高端医疗器械创新发展有关举措的公告》系列解读（一）-2025/7/14
2025-07-15查看详情 >
